OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

Top 3 AI Stocks to Invest in Right Now

Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties

Is Apple’s foldable iPhone Duo worth $2,000? See how it stacks up against other foldable phones.

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

Inside the push to weaken Washington’s toughest financial watchdog

Scared to spend your retirement money? Here’s one way to get over the fear of running out.

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

Dow Jones Futures: Market Rallies, But Must Do This; Meta, GE Lead 15 Stocks Near Buy Points

August 8, 2024

Dow Jones futures: The new market rally attempt had a strong Thursday, but hasn't proved itself. Meta and GE lead stocks near buy points Read More...

3rdPartyFeeds

Why Investors Were High on Cronos Group Today

August 8, 2024

Investors were clearly impressed by one particular metric in the company's freshly issued quarterly earnings report. Read More...

3rdPartyFeeds

Amazon axes a major fee for sellers ahead of the crucial holiday shopping rush

August 8, 2024

The elimination of inventory "overage" fees could provide some relief for sellers battling a slate of new fees this year. Read More...

3rdPartyFeeds

Mortgage rates, Lumen CEO, Good Buy or Goodbye: Market Domination

August 8, 2024

Stock market indexes (^DJI, ^IXIC, ^GSPC) and sectors are holding steady in positive territory ahead of Thursday's market close. Julie Hyman and Josh Lipton...

3rdPartyFeeds

AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals

August 8, 2024

On Thursday, Exscientia plc (NASDAQ:EXAI) agreed to merge with Recursion Pharmaceuticals Inc. (NASDAQ:RXRX). Exscientia shareholders will receive 0.7729...

3rdPartyFeeds

Cronos Group (CRON) Q2 2024 Earnings Call Transcript

August 8, 2024

CRON earnings call for the period ending June 30, 2024. Read More...

3rdPartyFeeds

The US economy is slowing, not collapsing: Raymond James CIO

August 8, 2024

It's been a rollercoaster ride on Wall Street this week. The major stock market indexes (^DJI,^GSPC, ^IXIC) closed in positive territory on Thursday after...

3rdPartyFeeds

Delta lashes out at CrowdStrike for its ‘vastly inadequate’ apology

August 8, 2024

The war of words over Delta’s massive service meltdown, set off by CrowdStrike’s disastrous software update, has grown ugly. Read More...

3rdPartyFeeds

E.l.f. Beauty sales jump 50% on gains in color cosmetics and skin care, launch of Bronzing Drops serum

August 8, 2024

E.l.f. Beauty has won over younger consumers with its viral marketing and low-priced "dupes" of prestige favorites. Read more...

3rdPartyFeeds

Paramount Global announces it will cut 15% of U.S. workforce, shares rise on second-quarter earnings

August 8, 2024

Paramount Global plans to cut 15% of its U.S. workforce as part of a broader $500 million cost reduction. Read more...

Previous 1 … 787 788 789 790 791 … 8,455 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.